-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2016_IP_MaskedStats.PDF
January 01, 2016 - MAJ O.R. 8,052 0.19
4: TRACH W MV >96 HRS OR PDX EXC FACE, MOUTH & NECK W/O MAJ O.R. 6,651 0.15
5: LIVER … TRANSPLANT W MCC OR INTESTINAL TRANSPLANT 197 0.00
6: LIVER TRANSPLANT W/O MCC 24 0.00
7: LUNG TRANSPLANT … , LIVER & SHUNT PROCEDURES W/O CC/MCC 144 0.00
408: BILIARY TRACT PROC EXCEPT ONLY CHOLECYST W OR W/ … EXCEPT MALIG,CIRR,ALC HEPA W MCC 8,238 0.19
442: DISORDERS OF LIVER EXCEPT MALIG,CIRR,ALC HEPA W CC … 10,368 0.24
443: DISORDERS OF LIVER EXCEPT MALIG,CIRR,ALC HEPA W/O CC/MCC 3,037 0.07
444: DISORDERS
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2015Q4_IP_MaskedStats.PDF
October 01, 2015 - MAJ O.R. 1,893 0.18
4: TRACH W MV >96 HRS OR PDX EXC FACE, MOUTH & NECK W/O MAJ O.R. 1,519 0.15
5: LIVER … & SHUNT PROCEDURES W MCC 165 0.02
406: PANCREAS, LIVER & SHUNT PROCEDURES W CC 88 0.01
407: PANCREAS … , LIVER & SHUNT PROCEDURES W/O CC/MCC 35 0.00
408: BILIARY TRACT PROC EXCEPT ONLY CHOLECYST W OR W/O … EXCEPT MALIG,CIRR,ALC HEPA W MCC 2,036 0.20
442: DISORDERS OF LIVER EXCEPT MALIG,CIRR,ALC HEPA W CC … 2,605 0.25
443: DISORDERS OF LIVER EXCEPT MALIG,CIRR,ALC HEPA W/O CC/MCC 805 0.08
444: DISORDERS OF
-
www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/about/profiles/profile_he.pdf
January 01, 2025 - underscoring the critical role of lab test results in accurate medical
diagnosis.3 Lab data, such as liver
-
hcup-us.ahrq.gov/reports/natstats/commdx/table1i.htm
February 11, 2011 - Liver disease, alcohol-related [150] 12,051 19.88 0.03 … Other liver diseases [151] 11,203 18.48 0.03
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Severity_V2.PDF
January 01, 2012 - comorbidity measure: Hypothyroidism 13,459,216 0 0.00 1.00 0.10 0.30
CM_LIVER : AHRQ comorbidity measure: Liver … Tuesday, September 26, 2017 3
Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of Total
1: Liver … Frequency
Percent
of Total
254: Other digestive system diagnoses 121,144 0.90%
260: Major pancreas, liver … disorders 40,189 0.30%
280: Alcoholic liver disease 26,034 0.19%
281: Malignancy of hepatobiliary … 26,506 0.20%
282: Disorders of pancreas except malignancy 103,565 0.77%
283: Other disorders of the liver
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_V2_Severity.PDF
January 01, 2011 - comorbidity measure: Hypothyroidism 13,915,176 0 0.00 1.00 0.10 0.30
CM_LIVER : AHRQ comorbidity measure: Liver … Tuesday, September 26, 2017 3
Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of Total
1: Liver … Frequency
Percent
of Total
254: Other digestive system diagnoses 124,337 0.89%
260: Major pancreas, liver … disorders 37,658 0.27%
280: Alcoholic liver disease 26,447 0.19%
281: Malignancy of hepatobiliary … 27,532 0.20%
282: Disorders of pancreas except malignancy 105,623 0.76%
283: Other disorders of the liver
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Severity_V2.PDF
January 01, 2010 - comorbidity measure: Hypothyroidism 13,907,610 0 0.00 1.00 0.09 0.29
CM_LIVER : AHRQ comorbidity measure: Liver … Tuesday, September 26, 2017 3
Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of Total
1: Liver … Frequency
Percent
of Total
254: Other digestive system diagnoses 122,564 0.88%
260: Major pancreas, liver … disorders 36,177 0.26%
280: Alcoholic liver disease 25,343 0.18%
281: Malignancy of hepatobiliary … 27,246 0.20%
282: Disorders of pancreas except malignancy 107,196 0.77%
283: Other disorders of the liver
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Severity.PDF
January 01, 2013 - comorbidity measure: Hypothyroidism 14,325,172 0 0.00 1.00 0.10 0.30
CM_LIVER : AHRQ comorbidity measure: Liver … Wednesday, November 4, 2015 4
Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of Total
1: Liver … hemorrhage 99,338 0.69%
254: Other digestive system diagnoses 126,602 0.88%
260: Major pancreas, liver … disorders 44,132 0.31%
280: Alcoholic liver disease 28,291 0.20%
281: Malignancy of hepatobiliary … Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of Total
283: Other disorders of the liver
-
hcup-us.ahrq.gov/db/nation/nis/APS-DRGsV20DefinitionsManual.pdf
January 13, 2015 - DRG DESCRIPTION
103 Heart Transplant
480 Liver Transplant
481 Bone Marrow Transplant
483 Trach … DRG DESCRIPTION
103 Heart Transplant
480 Liver Transplant
481 Bone Marrow Transplant
483 Trach … & SHUNT PROCEDURES
192 191 PANCREAS,LIVER & SHUNT PROCEDURES
193 193 BIL PROC, EX ONLY CHOLCYST … PROC
202 205 DISORDERS OF LIVER, EX MALIGNANCY
203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS … 204 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY
205 205 DISORDERS OF LIVER, EX MALIGNANCY
206 205
-
hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V21%20Definitions%20Manual.pdf
January 13, 2015 - DRG DESCRIPTION
103 Heart Transplant
480 Liver Transplant
481 Bone Marrow Transplant
483 Trach Vent … Yes
Yes
Yes
No
No
No
Liver
Transplant
Trach-
eostomy
Bone
Marrow
Transplant
Lung
Transplant … & SHUNT PROCEDURES
192 191 PANCREAS,LIVER & SHUNT PROCEDURES
193 193 BIL PROC, EX ONLY CHOLCYST … PROC
202 205 DISORDERS OF LIVER, EX MALIGNANCY
203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS … 204 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY
205 205 DISORDERS OF LIVER, EX MALIGNANCY
206 205
-
www.ahrq.gov/hai/tools/mvp/modules/technical/subglottic-fac-guide.html
January 01, 2017 - ICU, and patients involved in high-risk surgical procedures such as thoracic aortic aneurysm repair, liver
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
January 01, 2015 - specified metformin-based combinations of FDA-approved diabetes medications
(see Table 1) regarding liver … studies where everyone included has at least one of
the following comorbid conditions:
• End-stage liver … for
metformin vs. sulfonylureas except cancer; evidence is high grade from the prior
report):
§ Liver … § Neuropathy
• We will include studies addressing
the following safety outcomes for
KQ3:
§ Liver … less than 3 months; and safety outcomes besides hypoglycemia,
gastrointestinal side effects, and liver
-
hcup-us.ahrq.gov/reports/factsandfigures/2008/pdfs/section5_8.pdf
January 01, 2008 - conditions that accompanied a secondary SA diagnosis in 2008
included conditions affecting the pancreas, liver
-
psnet.ahrq.gov/node/50859/psn-pdf
January 31, 2020 - CT or
MRI is delivered, they can pull up the labs and say wait a minute, this patient has abnormal liver … function
tests, maybe I should take a look again at the shape of the liver and make sure that there
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2014_MaskedStats_Severity.PDF
January 01, 2014 - comorbidity measure:
Hypothyroidism 7,071,762 0 0.00 1.00 0.10 0.30
CM_LIVER : AHRQ comorbidity measure: Liver … Tuesday, October 4, 2016 5
Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of Total
1: Liver … Other hepatobiliary, pancreas & abdominal procedures 2,048 0.03%
279: Hepatic coma & other major acute liver … disorders 20,833 0.29%
280: Alcoholic liver disease 13,034 0.18%
281: Malignancy of hepatobiliary … Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of Total
283: Other disorders of the liver
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Severity.PDF
January 01, 2011 - comorbidity measure: Hypothyroidism 8,023,590 0 0.00 1.00 0.10 0.29
CM_LIVER : AHRQ comorbidity measure: Liver … 55 Monday, May 20, 2013 3
Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of
Total
1: Liver … Frequency
Percent
of
Total
254: Other digestive system diagnoses 65,942 0.82%
260: Major pancreas, liver … disorders 19,915 0.25%
280: Alcoholic liver disease 13,450 0.17%
281: Malignancy of hepatobiliary … 14,563 0.18%
282: Disorders of pancreas except malignancy 57,197 0.71%
283: Other disorders of the liver
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2015Q1Q3_Severity.PDF
November 08, 2017 - comorbidity measure: Hypothyroidism 5,377,720 0 0.00 1.00 0.10 0.30
CM_LIVER : AHRQ comorbidity measure: Liver … Wednesday, November 8, 2017 4
Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of Total
1: Liver … Frequency
Percent
of Total
254: Other digestive system diagnoses 44,319 0.82%
260: Major pancreas, liver … disorders 16,227 0.30%
280: Alcoholic liver disease 10,261 0.19%
281: Malignancy of hepatobiliary … 9,431 0.18%
282: Disorders of pancreas except malignancy 41,372 0.77%
283: Other disorders of the liver
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2013_MaskedStats_Severity.PDF
January 01, 2013 - comorbidity measure:
Hypothyroidism 7,119,563 0 0.00 1.00 0.10 0.30
CM_LIVER : AHRQ comorbidity measure: Liver … Thursday, January 14, 2016 5
Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of Total
1: Liver … Other hepatobiliary, pancreas & abdominal procedures 2,018 0.03%
279: Hepatic coma & other major acute liver … disorders 20,671 0.29%
280: Alcoholic liver disease 12,736 0.18%
281: Malignancy of hepatobiliary … Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of Total
283: Other disorders of the liver
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Severity.PDF
January 01, 2012 - comorbidity measure: Hypothyroidism 3,195,782 0 0.00 1.00 0.01 0.08
CM_LIVER : AHRQ comorbidity measure: Liver … Wednesday, July 16, 2014 4
Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of Total
1: Liver … Other hepatobiliary, pancreas & abdominal procedures 365 0.01%
279: Hepatic coma & other major acute liver … disorders 1,319 0.04%
280: Alcoholic liver disease 20 0.00%
281: Malignancy of hepatobiliary system … Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of Total
283: Other disorders of the liver
-
cds.ahrq.gov/sites/default/files/cds/artifact/21/2024_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
January 01, 2024 - Individuals who have an allergy to statin, are receiving palliative or hospice care, who have
active liver … • Patients with active liver disease or hepatic disease or insufficiency.
• Patients with ESRD. … 19
Location in
CDS Logic Concept Definition and/or Rationale
Denominator
exception
“active liver … hepatic disease or
insufficiency”
eCQM logic represents this phrase as three distinct data elements: liver … guidelines cite elevated ALT as a contraindication
for statins and has been used as a proxy for severe liver